1ISG-013 Economic impact of orphan drugs used in paediatric patients attending hospital outpatient pharmacy and day hospital
| Autor: | Concepcion Cañete, M Larrosa-Garcia, A Fernández-Polo, B Garcia-Palop, C Alonso Martinez, I Jimenez-Lozano, M Garau, L Betriu, MJ Cabañas, E Serramontmany, C Alerany |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Drug
Pediatrics medicine.medical_specialty business.industry Idursulfase media_common.quotation_subject Pharmacy Orphan drug Section 1: Introductory statements and governance Adalimumab Medicine media_common.cataloged_instance Day hospital European union business Outpatient pharmacy medicine.drug media_common |
| Zdroj: | Eur J Hosp Pharm |
| Popis: | BACKGROUND: Orphan drugs (ODs) are designed to treat rare diseases (RD), which are those affecting a small number of people (prevalence |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|